Shanghai Rightongene (China) Today
| 688217 Stock | 20.75 0.50 2.35% |
Performance10 of 100
| Odds Of DistressOver 58
|
Shanghai Rightongene is trading at 20.75 as of the 29th of November 2024, a 2.35% down since the beginning of the trading day. The stock's open price was 21.25. Shanghai Rightongene has over 58 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat ok returns during the last 90 days. Equity ratings for Shanghai Rightongene Biotechnology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of August 2024 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Shanghai Rightongene is entity of China. It is traded as Stock on SHG exchange. The company has 55.86 M outstanding shares. More on Shanghai Rightongene Biotechnology
Moving together with Shanghai Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shanghai Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shanghai Rightongene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shanghai Rightongene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman Personnel | Hui Xiong | ||||
| Thematic Idea | Biotech (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Shanghai Rightongene's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shanghai Rightongene's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Shanghai Rightongene can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shanghai Rightongene's financial leverage. It provides some insight into what part of Shanghai Rightongene's total assets is financed by creditors.
| |||||
Shanghai Rightongene Biotechnology (688217) is traded on Shanghai Stock Exchange in China and employs 501 people. Shanghai Rightongene is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanghai Rightongene's market, we take the total number of its shares issued and multiply it by Shanghai Rightongene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanghai Rightongene operates under Biotechnology sector and is part of Health Care industry. The entity has 55.86 M outstanding shares.
Shanghai Rightongene generates positive cash flow from operations, but has no cash available
Check Shanghai Rightongene Probability Of Bankruptcy
Ownership AllocationShanghai Rightongene shows a total of 55.86 Million outstanding shares. Shanghai Rightongene maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shanghai Ownership Details
Shanghai Rightongene Risk Profiles
Although Shanghai Rightongene's alpha and beta are two of the key measurements used to evaluate Shanghai Rightongene's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.33 | |||
| Semi Deviation | 3.87 | |||
| Standard Deviation | 4.64 | |||
| Variance | 21.5 |
Shanghai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai Rightongene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Shanghai Rightongene Corporate Executives
Elected by the shareholders, the Shanghai Rightongene's board of directors comprises two types of representatives: Shanghai Rightongene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Rightongene's management team and ensure that shareholders' interests are well served. Shanghai Rightongene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Rightongene's outside directors are responsible for providing unbiased perspectives on the board's policies.
Other Information on Investing in Shanghai Stock
Shanghai Rightongene financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rightongene security.